Greetings from Greece,
We have a new API manufacturer with CEP and a pharmaceutical product with six different strengths. How many batches of the finished product per strength should be manufactured and analyzed during the process validation study? We should use at least 2 different API batches or not? What are the guidelines for these cases?
Thanks in advance!